The Cardiovascular Outcomes Difference between Acalabrutinib and Zanubrutinib: A Retrospective Cohort Study Using Real-World Data
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Blood
Conference Name
American Society of Hematology (ASH) Annual Meeting
Conference Date
2024-12-07 - 2024-12-10
First Page
6783
DOI
10.1182/blood-2024-211603
Volume
144
Issue
Supplement 1
Publication Date
11-5-2024
Recommended Citation
Tang, Z., Aldapt, M. B., Chiang, C., & Gong, Z. (2024). The Cardiovascular Outcomes Difference between Acalabrutinib and Zanubrutinib: A Retrospective Cohort Study Using Real-World Data. Blood, 144 (Supplement 1), 6783. https://doi.org/10.1182/blood-2024-211603
COinS